Biofrontera Inc. Revenue 2020–2025
Biofrontera Inc. annual/quarterly revenue history and growth rate from 2020 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Biofrontera Inc. revenue for the quarter ending March 31, 2026 was 10.1 M, a 17.42% increase year-over-year.
- Biofrontera Inc. revenue for the twelve months ending March 31, 2026 was 34.7 M, a 3.06% increase year-over-year.
- Biofrontera Inc. annual revenue for 2025 was 41.7 M, a 11.75% increase from 2024.
- Biofrontera Inc. annual revenue for 2024 was 37.3 M, a 9.54% increase from 2023.
- Biofrontera Inc. annual revenue for 2023 was 34.1 M, a 18.82% increase from 2022.
- Biofrontera Inc. annual revenue for 2022 was 28.7 M.
Biofrontera Inc. (BFRI) — Frequently Asked Questions
Biofrontera Inc. (BFRI) is a publicly traded US company. It has a market capitalization of $9M. In fiscal 2025 it reported revenue of $42M and net income of -$11M. Explore BFRI's stock price, financial statements, earnings history, margins and key ratios below.
What is Biofrontera Inc.'s market cap?
Biofrontera Inc. (BFRI) has a market capitalization of $9M.
What is the BFRI stock price?
BFRI trades at $0.89 (+2.70% on the day).
How much revenue does Biofrontera Inc. make?
Biofrontera Inc. reported revenue of $42M in fiscal 2025.
Is BFRI profitable?
In fiscal 2025, Biofrontera Inc. reported net income of -$11M.